Rallybio Stock Quote RLYB - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.32

Bid

1.31

Ask

1.32

Volume

34,418

1.29 Day's Range 1.32

1.155 52 Week Range 6.38

Market Cap

53.884M

Previous Close

1.30

Open

1.31

Last Trade

1.31

Last Trade Time

11:59:39

Financial Volume

$ 44,874

VWAP

1.3038

Average Volume (3m)

232,137

Shares Outstanding

41,449,297

Dividend Yield

PE Ratio

-0.72

Earnings Per Share (EPS)

-1.8

Revenue

Net Profit

-74.56M

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening ... Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.rallybio.com.

Headquarters

Wilmington, Delaware, USA

Founded

1970

Rallybio Holdings LLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RLYB. The last closing price for Rallybio was $1.30. Over the last year, Rallybio shares have traded in a share price range of $ 1.155 to $ 6.38.

Rallybio currently has 41,449,297 shares outstanding. The market capitalization of Rallybio is $53.88 million. Rallybio has a price to earnings ratio (PE ratio) of -0.72.

Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today...

Rallybio Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations

– First Reported Large-Scale Analysis of FNAIT Risk Across Broad Population of Diverse Ancestries – – Topline Results Suggest a Significant Increase in the Number of Pregnancies at Higher Risk...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.07	-5.03597122302	1.39	1.42	1.155	258984	1.23289998	CS
4	-0.17	-11.4093959732	1.49	1.7291	1.155	212688	1.41445847	CS
12	-0.55	-29.4117647059	1.87	2	1.155	232137	1.64056035	CS
26	-0.78	-37.1428571429	2.1	3.46	1.155	927667	2.60585862	CS
52	-3.91	-74.7609942639	5.23	6.38	1.155	497678	2.66257584	CS
156	-13.6	-91.1528150134	14.92	25.78	1.155	230762	4.64318464	CS
260	-13.6	-91.1528150134	14.92	25.78	1.155	230762	4.64318464	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SNGXSoligenix Inc	$ 10.33 (416.50%)	94.94M
ATNF180 Life Sciences Corporation	$ 4.21 (159.88%)	14.97M
NBSTWNewbury Street Acquisition Corporation	$ 0.0731 (83.21%)	12.6k
QUREuniQure NV	$ 6.0091 (58.97%)	35.98M
PEGYPineapple Energy Inc	$ 1.855 (54.58%)	38.77M
INDVIndivior PLC	$ 9.68 (-36.90%)	1.73M
CLEUChina Liberal Education Holdings Ltd	$ 0.39 (-31.67%)	7.78M
HELEHelen of Troy Ltd	$ 63.70 (-28.44%)	3.41M
GVHGlobavend Holdings Ltd	$ 0.60 (-27.28%)	5.67M
TRNRInteractive Strength Inc	$ 0.9361 (-26.87%)	14.42M
NVDANVIDIA Corporation	$ 131.35 (2.46%)	151.28M
MAXNMaxeon Solar Technologies Ltd	$ 0.2356 (-12.74%)	125.1M
SNGXSoligenix Inc	$ 10.33 (416.50%)	94.94M
TSLATesla Inc	$ 259.7338 (2.69%)	69.18M
SQQQProShares UltraPro Short QQQ	$ 7.375 (-0.34%)	50.21M